Buscar





Buscar





Mercado
/
Acciones
/
nasdaq-gkos
/

Glaukos Corp

GKOS

Añadir a la lista de seguimiento

137.230USD

+0.870+0.64%

Cierre 05/13, 16:00（ET）Cotizaciones retrasadas 15 min

7.89BCap. mercado

PérdidaP/E TTM



Glaukos Corp

137.230

+0.870+0.64%

Descripción general Finanzas Discusiones Análisis Compañía

Descripción general

Finanzas

Discusiones

Análisis

Compañía

Más Datos de Glaukos Corp Compañía

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Información de Glaukos Corp



Símbolo de cotizaciónGKOS

Nombre de la empresaGlaukos Corp

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoBurns (Thomas William)

Número de empleados995

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 25

Dirección1 Glaukos Way

CiudadALISO VIEJO

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal92656

Teléfono19493679600

Sitio Webhttps://www.glaukos.com

Símbolo de cotizaciónGKOS

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoBurns (Thomas William)

Ejecutivos de Glaukos Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.70M

+4.98%

Mr. David F. Hoffmeister

Independent Director

70.09K

-0.25%

Mr. Mark J. Foley

Lead Independent Director

57.22K

-0.53%

Dr. Tomas Navratil

Chief Development Officer

50.58K

-4.49%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.69K

+1.65%

Mr. Marc A. Stapley

Independent Director

36.72K

-0.51%

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

Mr. Joseph E. Gilliam

President, Chief Operating Officer

Dr. Leana S. Wen, M.D.

Independent Director

Ms. Denice M. Torres, J.D.

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.70M

+4.98%

Mr. David F. Hoffmeister

Independent Director

70.09K

-0.25%

Mr. Mark J. Foley

Lead Independent Director

57.22K

-0.53%

Dr. Tomas Navratil

Chief Development Officer

50.58K

-4.49%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.69K

+1.65%

Mr. Marc A. Stapley

Independent Director

36.72K

-0.51%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Glaucoma

421.07M

82.98%

Corneal Health

86.37M

17.02%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

375.04M

73.91%

International

132.40M

26.09%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Glaucoma

421.07M

82.98%

Corneal Health

86.37M

17.02%

Estadísticas de accionistas

Actualizado: lun., 11 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.75%

PRIMECAP Management Company

5.74%

Vanguard Portfolio Management, LLC

5.46%

Janus Henderson Investors

5.14%

Vanguard Capital Management, LLC

4.27%

Otro

65.64%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.75%

PRIMECAP Management Company

5.74%

Vanguard Portfolio Management, LLC

5.46%

Janus Henderson Investors

5.14%

Vanguard Capital Management, LLC

4.27%

Otro

65.64%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.27%

Investment Advisor/Hedge Fund

31.21%

Hedge Fund

11.62%

Individual Investor

3.59%

Research Firm

1.93%

Pension Fund

1.52%

Sovereign Wealth Fund

0.91%

Bank and Trust

0.79%

Venture Capital

0.50%

Participación institucional



Actualizado: dom., 5 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

702

59.35M

101.04%

-2.78M

2025Q4

679

58.33M

101.56%

-6.75M

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

8.07M

13.9%

+267.99K

+3.43%

Dec 31, 2025

PRIMECAP Management Company

3.38M

5.81%

+1.12M

+49.83%

Dec 31, 2025

Janus Henderson Investors

3.02M

5.2%

+1.95M

+183.40%

Dec 31, 2025

State Street Investment Management (US)

2.12M

3.65%

+18.04K

+0.86%

Dec 31, 2025

Burns (Thomas William)

1.62M

2.78%

+11.71K

+0.73%

Mar 25, 2026

AllianceBernstein L.P.

1.64M

2.83%

-90.03K

-5.19%

Dec 31, 2025

Millennium Management LLC

1.61M

2.77%

+696.29K

+76.23%

Dec 31, 2025

Geode Capital Management, L.L.C.

1.32M

2.27%

+1.56K

+0.12%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Invesco S&P SmallCap Health Care ETF

3.09%

Alger Weatherbie Enduring Growth ETF

2.07%

State Street SPDR S&P Health Care Equipment ETF

1.79%

ROBO Global Healthcare Technology & Innovation ETF

1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.65%

iShares S&P Small-Cap 600 Growth ETF

0.64%

iShares U.S. Medical Devices ETF

0.6%

OneAscent Enhanced Small and Mid Cap ETF

0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

0.51%

Invesco S&P SmallCap Health Care ETF

Proporción3.09%

Alger Weatherbie Enduring Growth ETF

Proporción2.07%

State Street SPDR S&P Health Care Equipment ETF

Proporción1.79%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

Proporción0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

Proporción0.65%

iShares S&P Small-Cap 600 Growth ETF

Proporción0.64%

iShares U.S. Medical Devices ETF

Proporción0.6%

OneAscent Enhanced Small and Mid Cap ETF

Proporción0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

Proporción0.51%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

